热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
APC anti-human IFN-γ Antibody
产品名称：
APC anti-human IFN-γ Antibody
产品类别：
抗体
产品编号：
506510
产品应用：
506510
[价格]
规格 价格 库存
100tests ￥ 3984 1

产品详情

Product Details

Verified Reactivity
Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, African Green, Pigtailed Macaque, Sooty Mangabey
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
E. coli-expressed recombinant human IFN-γ
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.

Excitation Laser
Red Laser (633 nm)
Application Notes

Flow Cytometry2: The fluorochrome-labeled B27 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IFN-? -producing cells within mixed cell populations. For intracellular cytokine staining protocol, please visit www.biolegend.com and click on the support section.
Neutralization1,3,6,7: The Ultra-LEAF? Purified antibody (Endotoxin <0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for neutralization of human IFN-? bioactivity (Cat. No. 506531).

Application References

(PubMed link indicates BioLegend citation)
  1. Favre C, et al. 1989. Molec. Immunol. 26:17. (Neut)
  2. Kaur A, et al. 2002. J Virol. 76:3646.
  3. Abrams J, et al. 1992. Immunol. Rev. 127:5. (Neut)
  4. Andersson U, et al. 1999. Detection and quantification of gene expression. New York:Springer-Verlag.
  5. Rout N, et al. 2010. PLoS One 5:e9787. (FC)
  6. Acosta-Rodriguez EV, et al. 2007. Nat. Immunol. 9:942-9. (Neut)
  7. Gangur V, et al. 1998. FASEB J. 12:705-13. (Neut)
Product Citations
  1. Nesterenko PA, et al. 2021. Cell Rep. 37:110167. PubMed
  2. Laurent A, et al. 2014. PLoS One. 9:103683. PubMed
  3. Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed
  4. Marques RM, et al. 2021. Cell Death Differ. 28:3140. PubMed
  5. Cheng L, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  6. Costa-Martins AG, et al. 2021. Cell Rep Med. 2:100465. PubMed
  7. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  8. Kan S, et al. 2020. Int J Oncol. 57:1047. PubMed
  9. Blandine Monel et al. 2019. Cell reports. 27(1):142-153 . PubMed
  10. Torres-Ruiz J, et al. 2021. Front Immunol. 12:689966. PubMed
  11. Juno JA, et al. 2020. Nat Med. 26:1428. PubMed
  12. R?lle A, et al. 2018. Cell Rep. 24:1967. PubMed
  13. Alrubayyi A, et al. 2021. Nat Commun. 12:5839. PubMed
  14. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  15. Godbersen C, et al. 2017. Mol Cancer Ther. 16:1335. PubMed
  16. Zhuang X, et al. 2019. Cancer Immunol Res. 0.94375. PubMed
  17. Johnson JK, et al. 2022. Methods Mol Biol. 2470:641. PubMed
  18. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  19. Matsuzawa T, et al. 2017. J Dermatol Sci. 10.1016/j.jdermsci.2017.03.015. PubMed
  20. Salvany‐Celades M et al. 2019. Cell Rep. 27(9):2537-2547 . PubMed
  21. Qiu X, et al. 2013. Sci Transl Med. 16:207. PubMed
  22. Robert R, et al. 2017. PLoS One. 10.1371/journal.pone.0184278. PubMed
  23. Min HK, et al. 2021. Immune Netw. 21:e43. PubMed
  24. Marzan-Rivera N, et al. 2022. iScience. 25:104764. PubMed
  25. Lee IK, et al. 2020. Cancers (Basel). 12:. PubMed
  26. Nesterenko PA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
RRID
AB_315443 (BioLegend Cat. No. 506510)

Antigen Details

Structure
Cytokine; dimer; 20-25 kD (Mammalian)
Bioactivity
Antiviral/antiparasitic activities; inhibits proliferation; enhances MHC class I and II expression on APC
Cell Sources
CD8+ and CD4+ T cells, NK cells
Cell Targets
T cells, B cells, macrophages, NK cells, endothelial cells, fibroblasts
Receptors
IFN-γRα (CDw119) dimerized with IFN-γRβ (AF-1)
Cell Type
Tregs
Biology Area
Cell Biology, Immunology, Neuroinflammation, Neuroscience
Molecular Family
Cytokines/Chemokines
Antigen References

1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press San Diego.
2. De Maeyer E, et al. 1992. Curr. Opin. Immunol. 4:321.
3. Farrar M, et al. 1993. Annu. Rev. Immunol. 11:571.
4. Gray P, et al. 1987. Lymphokines 13:151.

Regulation
Upregulated by IL-2, FGF-basic, EGF; downregulated by vitamin D3 or DMN; labile at pH2
Gene ID
3458 View all products for this Gene ID
UniProt
View information about IFN-gamma on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线